id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-1292-0002,FDA,FDA-2024-E-1292,"Patent Term Extension Application for FILSUVEZ Patent No 9,827,214",Other,Application,2024-03-18T04:00:00Z,2024,3,2024-03-18T04:00:00Z,,2024-03-18T15:58:48Z,,0,0,090000648647da97
FDA-2024-E-1292-0001,FDA,FDA-2024-E-1292,Letter from U. S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-03-18T04:00:00Z,2024,3,2024-03-18T04:00:00Z,,2024-03-18T15:58:44Z,,0,0,090000648647da93